Langerhans cells (LCs) are epidermis-resident antigen-presenting cells that share a common ontogeny with macrophages but function as dendritic cells (DCs). Their development, recruitment and retention in the epidermis is orchestrated by interactions with keratinocytes through multiple mechanisms. LC and dermal DC subsets often show functional redundancy, but LCs are required for specific types of adaptive immune responses when antigen is concentrated in the epidermis. This Review will focus on those developmental and functional properties that are unique to LCs.
r e v i e w Langerhans cells (LCs) are the only antigen-presenting cells that express major histocompatibility complex (MHC) class II under steady-state conditions in the epidermis, the outermost cellular layer of the skin. They were initially observed by Paul Langerhans in 1868 and were thought to function as part of the peripheral nervous system, but landmark studies 40 years ago placed them firmly within the hematopoietic system [1] [2] [3] [4] . Early work by Ralph Steinman and others approximately 30 year ago found that immature LCs and dendritic cells (DCs) efficiently acquire and process antigen 5, 6 . Exposure of LCs and DCs to activating stimuli allows highly efficient activation of naive T cells in mixed-lymphocyte reactions. Inflammatory stimuli also greatly enhance the migration of LCs out of the epidermis and into regional lymph nodes (LNs). Thus, LCs were considered the prototypical migratory DCs envisioned by the DC paradigm, which also led to coinage of the term 'LC paradigm' 7 . A corollary of the DC paradigm is that the presentation of self antigen by DCs or LCs in the absence of inflammatory stimuli deletes or silences autoreactive T cell clones and thereby provides a basis for peripheral self-tolerance 8 . The location of LCs at a barrier surfaces provides them access to skin pathogens, commensal organisms, allergens, contact sensitizers and epidermal self antigens. Thus, LCs were assumed to mediate the initiation of adaptive immunity to foreign antigens and tolerance to self antigens present in the skin.
Subsequently, there has been considerable progress in the investigation of skin DCs. Notably, several subsets of dermal DCs have been identified and have been shown to be required for many of the functions originally ascribed to LCs. The phenotypes ( Table 1) and functions of skin antigen-presenting cell subsets have been reviewed 9 . In addition, LCs have been found to be closely related to macrophages, on the basis of a shared ontogeny 10, 11 . Thus, LCs are turning out to be a unique cell type. This Review will explore the unique aspects of mouse LC biology and the contribution these cells provide to the establishment and regulation of cutaneous immune responses.
Development and maintenance of the epidermal LC network
During ontogeny, primitive myeloid progeitor cells, initially from the yolk sac and later from the fetal liver, seed the skin 11 (Fig. 1) . On day 2 after birth, these cells undergo a 10-to 20-fold population expansion during which they assume a dendritic morphology and begin to express the surface markers MHC class II and the C-type lectin receptor Langerin (CD207) in a step-wise manner, with ultimate establishment of the adult LC network by 3 weeks of age 12, 13 . LC differentiation requires several transcription factors related to signaling via the cytokine TGF-β, including Runx3 and Id2, as well as engagement of the receptor CSF1R (M-CSFR) by the cytokine IL-34 derived from keratinocytes (KCs) 10, [14] [15] [16] [17] . Once formed, adult LCs form a selfrenewing, radio-resistant population within the epidermis 18 .
Notably, LC ontogeny is clearly distinct from classic DC development. DCs arise from bone-marrow precursors, require the cytokine Flt3L, have a short half-life and do not undergo self-renewal. LC development more closely resembles that of other tissue macrophages, particularly microglia. Like microglia, LCs arise from primitive myeloid progenitor cells and require IL-34 derived from tissues 16, 19 . That observation is further supported by the fact that macrophage populations can undergo self-renewal in peripheral tissues. Thus, it has been proposed that LCs should be considered a subset of tissue macrophages akin to microglia in the brain, alveolar macrophages in the lungs and Kupffer cells in the liver 20, 21 . While this makes sense on the basis of ontogeny, it neglects the fact that LCs, unlike tissue macrophages, have the ability to migrate into regional LNs. The geneexpression profile of LCs matches that of other migratory DC populations, and they can efficiently prime naive T cells 22, 23 . That is a critical function not shared with tissue macrophages. The dichotomy between ontogeny and function probably results from tissue programming of precursor cells by the epidermis, as has been demonstrated with macrophages by adoptive transfer between tissues [24] [25] [26] . Thus, while LCs in the skin share many features with tissue macrophages and have been speculated to have macrophage-like functions while skin resident, they also clearly function as DCs. Thus, LCs are a unique, hybrid cell type probably best considered a specialized form of DC.
TGF-β1 is particularly important for the development of the LC network. In vitro culture of precursors of hematopoietic stem cells in the presence of TGF-β1 yields LCs. Mice that lack the transcription factors Id2, Runx3 or PU.1, as well as Axl, which are all involved with TGF-β1 responses, lack or have fewer LCs 14, 15, 27, 28 . BMP7, a member of the TGF-β superfamily, is required for optimal LC development 29 . Finally, Tgfb1 −/− mice lack LCs 30 . Interestingly, TGF-β1 signaling is also needed to maintain the LC network after it has developed. In mice with conditional ablation of Tgfbr1 or Tgfbr2 or genes such as Lamtor2 (which encodes a component of the TGF-β pathway) in LCs, the LCs lose the ability to remain in the epidermis and spontaneously migrate into regional LNs [31] [32] [33] . Similarly, ablation of Tgfb1 in differentiated LCs results in spontaneous homeostatic LC migration 32, 34 . Thus, despite many sources of TGF-β1 in the epidermis (for example, KCs, γδ T cells and LCs), LCs depend on autocrine and/or paracrine TGF-β1 for epidermal residence. TGF-β1 signaling is also sufficient to prevent homeostatic LC migration, as in mice in which LCs express a mutant, constitutively active form of the TGF-β receptor TGF-βRI, the LCs fail to migrate to regional LNs under steady-state conditions 35 ( Fig. 2) . TGF-β1 is secreted as an inactive, latent form in complex with latency-associated peptide and, in the epidermis, requires activation by the integrin α V β 6 or integrin α V β 8 , which are expressed by non-overlapping subsets of KCs (α V β 6 is expressed in the interfollicular regions; α V β 8 is expressed near the hair follicles) 35, 36 . Thus, transactivation of LC-derived TGF-β1 by integrins expressed by KCs is needed to maintain the epidermal residence of LCs under non-inflammatory conditions. TGF-β1 signaling is required for expression of Axl that has antiinflammatory effects and might act on LCs as well as KCs to inhibit LC migration 28 . From that, the inference is reasonably made that the expression of α V β 6 or α V β 8 by KCs, probably in conjunction with additional signaling, might be an event required for homeostatic LC migration.
LCs undergo self-renewal and remain of host origin in mouse bone-marrow-transplantation models 18, 37, 38 . LCs can repair DNA damage through the action of the cyclin-dependent kinase inhibitor CDKN1A, which permits cell-cycle arrest that provides protection against ionizing radiation 39 . However, strong inflammatory stimuli such as ultraviolet (UV) light can result in depletion of LCs 10 . In this context, Gr1 hi monocytes dependent on the chemokine receptor CCR2-are recruited into the epidermis to replace LCs that have migrated 10 (Fig. 1) . Recruitment of the precursors of monocytes into the epidermis occurs at the hair follicle and requires the chemokine receptors CCR2 and CCR6 (ref. 40) . The ligand for CCR2 (CCL2) is expressed at the follicular isthmus and the ligand for CCR6 (CCL20) is expressed at the follicular infundibulum. LCs are excluded from the immunologically privileged bulge region containing KC stem cells by the chemokines CCL8 and CCR8. Interestingly, LCs derived from Gr1 hi monocytes arise independently of TGF-β and are short-lived in the epidermis. They are replaced by a second wave of steady-statederived long-term LCs 41 . The biological importance of these transient monocyte-derived LCs has remained unclear, although there is evidence to suggest that they participate in inflammatory cytokine circuits in psoriatic skin 42, 43 .
Activation-induced LC migration
Exposure to UV light and haptens are the best studied inflammatory stimuli that lead to the activation and migration of LCs. Activated LCs have reduced expression of E-cadherin that forms a structural tether with E-cadherin-expressing KCs, which allows their egress from the epidermis 44 . Migration from the epidermis is facilitated by CXCR4 and the adhesion molecule EpCAM [45] [46] [47] . Activated LCs begin to express CCR7 and, once in the dermis, follow a CCL19 and CCL21 chemokine gradient through the dermal lymphatics and into the paracortex of the skin-draining LNs 48 .
LC migration is triggered by the coordinated action of the inflammatory cytokines IL-1β, IL-18 and TNF, since mice given blocking antibodies to those cytokines and Casp1 −/− , Il1b −/− or Tnfr2 −/− mice show decreased hapten-induced LC migration [49] [50] [51] [52] [53] . It remains unclear, however, whether those cytokines act directly on LCs or act indirectly via KCs (Fig. 2) . LC migration in response to haptens or infection with Candida albicans is unaffected in mice with a selective LC ablation of the adaptor MyD88 that renders them insensitive to IL-1β and IL-18 as well as to Toll-like receptor 2 (TLR2) ligands found in the C. albicans cell wall 54 . In contrast, mice with KC-specific ablation of MyD88 have less LC migration in response to immunization with protein 55 . In addition, UV exposure reduces the capacity of KCs to provide active TGF-β to LCs, and constitutive TGF-β signaling in LCs inhibits both UV-light-induced expression of CCR7 and LC migration 35 . Thus, KCs have an important role in facilitating LC migration 56 and, in at least some contexts, regulated transactivation of TGF-β by KCs might act as a trigger for LC migration.
LCs and priming of adaptive T cell responses
Despite intense focus by many laboratories, the precise function of LCs has remained controversial, largely due to the use of varying techniques. Early work focused on LCs in culture. However, the finding that LCs selectively express Langerin was a major breakthrough 57 . The use of Langerin as a LC marker greatly facilitated the analysis of LCs ex vivo and allowed the engineering of three independently derived mouse lines in which LCs are efficiently ablated ( Table 2 ). The primate diphtheria toxin receptor (DTR) was introduced into the endogenous locus encoding Langerin to create two lines of murine Langerin-DTR (muLangerin-DTR) mice 58, 59 . Human genomic DNA (bacterial artificial chromosome) containing the locus encoding Langerin modified to express active diphtheria toxin (DTA) or DTR was used to create mice with transgenic expression of human Langerin-DTA (huLangerin-DTA) or huLangerin-DTR, respectively 60, 61 . It was later discovered that dermal cDC1s (CD103 + dDCs) and other cDC1s (LN-and spleenresident CD8 + DCs) on the C57BL/6 genetic background also express Langerin. This clearly complicated interpretation of the early work studying muLangerin-DTR mice and analyzing LCs on the basis of Langerin expression. In huLangerin-DTA and huLangerin-DTR mice, LCs are selectively targeted, since transgene expression recapitulates the human pattern of Langerin expression in LCs but not cDC1s.
Those early technical problems have now been largely overcome. The phenotype of LCs is now well characterized, and they can be easily and reliably isolated from LNs via their expression of several markers, including CD11c, MHC class II, Langerin and CD11b, and lack of expression of the marker CD103 ( Table 1) . For selective ablation of LCs in muLangerin-DTR mice, diphtheria toxin (DT) can be administered 1-2 weeks before experimentation 62 (Table 2) . Since LCs repopulate the epidermis after ablation more slowly than dermal cDC1s do under steady-state conditions, there is a window after the administration of DT during which LCs are absent but dermal cDC1s have largely recovered. muLangerin-DTR mice are also commonly used as recipients in bone-marrow-chimera experiments. Since LCs are radio-resistant and undergo self-renewal, they remain of host origin in chimeras 18 . Thus, administration of DT to chimeras generated by the transfer of wild-type bone marrow into muLangerin-DTR host mice targets LCs but not dermal cDC1s that have undergone repopulation from cells of donor origin. Although these approaches all have their caveats, there is now a large body of literature (which will be explored below) that has accurately assessed the requirements for LCs in vivo across many contexts (Fig. 3) .
LCs in cross presentation
The presentation of exogenous antigen by DCs requires specialized processing and cross-presentation, a function critical for cytotoxic Table 1 ). The dermis is populated by two main subsets of DC that arise from dedicated pre-DC precursor cells in the bone marrow. Dermal cDC1s are closely related to cDC1s in secondary lymphoid tissues. Dermal cDC1s are often called 'XCR1 + dDCs', 'CD103 + dDCs' or 'IRF8 + dDCs' on the basis of their surface marker expression and transcription factor dependence. Dermal cDC2s are closely related to cDC2s in secondary lymphoid tissue and are often called 'CD11b + dDCs' or 'IRF4 + dDCs'. A less-well-characterized DC subset called 'double-negative DCs' (DNDC), on the basis of their lack of expression of CD103 and CD11b, as well as macrophages and monocytederived DCs (moDC), also reside in the dermis. During inflammation, monocyte-derived LCs are recruited into the epidermis at the follicular isthmus and infundibulum but are excluded from the bulge region. HSC, hematopoietic stem cell.
r e v i e w T cell responses to viruses, intracellular pathogens and tumors. Targeting antigen to the correct DC subsets for cross-presentation is an important goal of effective vaccine design. In general, mouse and human dermal cDC1s have an ability superior to that of LCs in presenting particulate or necrotic-cell-derived antigens for crosspriming to CD8 + T cells, particularly in the context of TLR3 costimulation [63] [64] [65] . In the context of cutaneous infection, Batf3 −/− mice, which are deficient in cDC1s, but not mice lacking LCs, are unable to mount a CD8 + T cell response to epicutaneous infection with C. albicans or herpes simplex virus, prime commensal specific IL-17-secreting CD8 + T cells and cannot reject of syngeneic tumors [66] [67] [68] [69] . Moreover, dermal cDC1s cross-prime KC-derived self antigens to CD8 + T cells more efficiently than LCs do, suggestive of a role for dermal cDC1s in cross-tolerance 67, 70 . Despite the fact that LCs are less efficient than cDC1s, there is evidence that LCs are capable of cross-presenting antigen to CD8 + T cells in certain contexts. In vitro, antigen-pulsed LCs can cross-present antigen 71 . LC-deficient mice develop reduced immunity mediated by cytotoxic T lymphocytes following cutaneous immunization with antigen-conjugated nanoparticles 72 . LCs targeted in vivo with foreign antigen via antibody to Langerin conjugated to antigen in the presence of certain adjuvants results in the proliferation of CD8 + T cells but functional tolerance (for example, cross-tolerance), not cross priming 73 . Finally, like most DCs, LCs can present endogenous antigen to CD8 + T cells, which results in direct tolerance or direct priming in the presence of an adjuvant 74 . In the context of graft-versus-host disease in which LCs are a source of alloantigens, LCs within the skin are needed to license pathogenic CD8 + effector T cells 75 .
LCs and T H 17 differentiation
The T H 17 subset of helper T cells protects against extracellular fungal and bacterial pathogens and can be pathogenic in autoimmune diseases such as psoriasis. LCs are required for the development of T H 17 responses to epicutaneous infection of the skin with C. albicans and provide protection against subsequent cutaneous infection with C. albicans but not against subsequent systemic infection with C. albicans 66, 76, 77 . In this context, LCs engaging with ligands for the C-type lectin receptor Dectin-1 expressed by C. albicans yeast are a non-redundant source of IL-6, a key cytokine required for T H 17 differentiation. The absence of LCs has no effect on T H 1 differentiation in this model. Mice with KC-specific ablation of the protease ADAM17 develop spontaneous cutaneous dysbiosis with overgrowth of Staphylococcus aureus. In this model, LCs are required for the generation of IL-17-producing CD4 + and γδ T cells in the skin 78 . The ability to promote T H 17 differentiation is not unique to LCs, as cDC2s are required for the generation of T H 17 cells directed against bacterial and fungal pathogens in tissues other than skin 79, 80 . T H 17 differentiation in response to epicutaneous infection with C. albicans depends on LCs and not dermal cDC2s, because the ligand for Dectin-1 is available mainly on C. albicans yeast forms found in the epidermis, not hyphal forms found in the dermis. The same is probably true in ADAM17-deficient mice, in which dysbiotic S. aureus remain superficial on the skin. Thus, LCs are required for T H 17 differentiation particularly when antigen is concentrated in the epidermis.
LCs and T FH and T H 2 differentiation The development of humoral immunity to cutaneous antigen involves the induction of CD4 + follicular helper T cells (T FH cells) that promote the development of plasma cells and germinal centers (GCs).
LCs can acquire epicutaneously applied antigen and are required for the production of protective immunoglobulin G1 (IgG1) in a model of staphylococcal scalded-skin syndrome 81, 82 . LC-deficient mice have diminished GC and T FH cell responses after intradermal immunization and infection with Leishmania major 83, 84 . Foreign antigen targeted selectively to LCs expands T FH cell populations and promotes GC formation, which results in antigen-specific IgG1; this indicates that antigen presentation by LCs is sufficient to promote a humoral response 85 . However, the ability to promote humoral responses is not unique to LCs. Foreign antigen, but not self antigen, targeted to cDC1s even in the absence of adjuvant induces T FH cell population expansion, GC formation and protective antibody responses 86, 87 . In addition, T FH cell and GC responses to intradermal immunization with nanoparticles require DC migration but are abolished only partially by the absence of LCs, while GC formation in response to hapten that penetrates deep into skin is independent of LCs 84 . Thus, it appears that LCs, like other subsets of DCs, have the ability to promote humoral responses.
LCs might have a special function in the development of IgE. Epicutaneous immunization with ovalbumin results in antigenspecific IgE that is diminished in abundance in mice lacking LCs and in mice with LC-specific ablation of the receptor for the cytokine TSLP 88 . In addition, LC-deficient mice have reduced steady-state concentrations of serum IgE. In this model, LCs are not required for T cell proliferation but are required for optimal IL-4 expression in skin-draining LNs, suggestive of a possible role in T H 2 differentiation. However, T H 2 differentiation in response to house dust mites is clearly diminished in mice in which all DCs are depleted of IRF4, which results in the inability of dermal cDC2s to migrate from the skin; this indicates a requirement for dermal cDC2s but not LCs in this process 89 . The abundance of antigenspecific IgE and IgG1 is decreased after dermal injection of antigen Model (far left) indicates the experimental system for LC depletion showing the specificity for LC compared with other skin dendritic cells and potential caveats for the method. DETC, dendritic epidermal T cells; BAC, bacterial artifcial chromosome; WT→muLangerin-DTR BM chimera, chimera generated by the transfer of wild-type bone marrow into a muLangerin-DTR host mouse.
r e v i e w into those mice, but this is not observed after dermal infection with the helminth Nippostrongylus brasilliensis in MGL2-DTR mice, in which cDC2s as well as macrophage populations are ablated 90, 91 . T H 2 differentiation in the intradermal papain model is not affected by the absence of LCs, and ablation of STAT5, a factor required for TSLP signaling, in LCs does not reduce T H 2 differentiation in response to epicutaneous challenge with the hapten FITC 91, 92 . Thus, LCs can promote IgE production in response to epicutaneous immunization with protein, but their ability to promote T H 2 differentiation appears to be limited.
LCs and tolerance induction
The concept that the presentation of antigen by immature DCs promotes anergic or immunosuppressive T cells that support peripheral tolerance has been well established by classic antigen-targeting experiments [93] [94] [95] . That is probably true for LCs as well, since resting human LCs activate and induce the proliferation of skin-resident regulatory T cells (T reg cells) in vitro, whereas activated LCs 'preferentially' induce the proliferation of effector memory T cells 96 . Those experiments analyzed skin-resident memory cells, and it is less clear whether LCs have a special ability to induce tolerance. Targeting antigen to LCs in vivo promotes T reg cell proliferation, but this appears to be restricted to self antigen and does not occur with foreign antigen 85, 97 . In the specific context of infection with L. major, LCs suppress responses directed against L. major, possibly through the population expansion of T reg cells 98 . In mouse models of allergic contact dermatitis, pretreatment with a precise dose of the innocuous hapten DNTB can tolerize the mice to subsequent sensitization with DNFB, a strong sensitizer, through a mechanism that require LCs for CD8 + T cell tolerance and activation of T reg cells 99 . Thus, there are specific situations in which LCs seem to promote tolerance that might be related to the restriction of antigen to the epidermis. However, the promotion of tolerance is not an attribute specific to LCs, since all migratory DCs share a similar immunosuppressive gene-expression profile, and subsets of dermal DCs also promote tolerance [100] [101] [102] [103] . Moreover, mice with constitutive ablation of LCs or other individual DC subsets have not been reported to develop autoimmunity. Thus, individual skin DC subsets are probably sufficient but redundant for peripheral tolerance in most contexts.
LCs and contact hypersensitivity
Contact hypersensitivity (CHS) is a mouse model of human allergic contact dermatitis 104 . In general, small-molecule sensitizing haptens that penetrate the skin are used to immunize mice, and the effector response is measured after application of the same hapten at a distant site. Selective ablation of LCs in muLangerin-DTR mice via either the delayed-immunization technique or bone-marrow-chimera technique ( Table 2 and discussed above) does not affect CHS responses 62, 105 . However, a requirement for LCs has been observed with low doses of hapten that might concentrate antigen in the epidermis 106 . Urushiol, the active sensitizer in poison ivy, is presented to T cells on CD1a, an antigen-presenting molecule with high expression by human LCs but not by mouse LCs 107 . Transgenic mice expressing human CD1a on LCs have greatly increased CHS responses to urushiol 108 . Thus, in humans, LCs are probably the key antigen-presenting cells in allergic contact dermatitis in response to antigens presented via CD1a, but in mice, their role is limited to contexts in which the antigen is mainly epidermal. In contrast to data obtained with muLangerin-DTR models of LC ablation, CHS in response to various haptens at a range of doses is reliably enhanced in huLangerin-DTA mice with constitutive and selective absence of LCs 60, 109 . Acute ablation of LCs in huLangerin-DTR mice before sensitization also increases CHS responses, although the effect is less pronounced and less consistent than that obtained with huLangerin-DTA mice 61 . Cells isolated from the LNs of huLangerin-DTA mice can elicit exaggerated CHS responses after adoptive transfer. Mice with constitutive LCspecific ablation of MHC class II or IL-10 also have increased CHS responses, but mice with LC-specific ablation of Myd88 do not 54, 109 . Notably, delayed-type hypersensitivity responses to C. albicans are also enhanced in huLangerin-DTA mice 66 . A similar exaggerated response is observed after intradermal injection of C. albicans into naive huLangerin-DTA mice 110 . This occurs only in the context of constitutive ablation of LCs or long-term depletion of LCs (unpublished data) and can be elicited in wild-type mice after Figure 3 Mouse skin DC subsets drive distinct T cell phenotypes. LCs, dermal cDC1s and dermal cDC2s promote distinct but overlapping T cell phenotypes. In most contexts, the same antigen is present in both the epidermis and dermis, which results in redundancy between LCs and dermal DC subsets. A requirement for LCs is observed mainly when antigens or adjuvants are confined to the epidermis.
r e v i e w adoptive transfer of liver-resident type 1 innate lymphoid cells. These data raise the possibility that LCs might indirectly suppress cutaneous immunological responsiveness or that the long-term absence of LCs might promote an as-yet-unidentified compensatory inflammatory response.
Concluding thoughts and future perspectives
The past several years have seen substantial progress in the understanding of mouse LC biology. The recognition that the LC is only one of several antigen-presenting-cells in the skin and the development of tools for the accurate identification and targeting of LCs have allowed more detailed and nuanced study of LCs. It is now appreciated that LCs are a unique cell type with a close ontogenetic relationship with macrophages and a close functional relationship with DCs. So far, most of the functional analysis of LCs has focused on their ability to drive antigen-specific T cell responses. LCs are clearly involved in T H 17 and T FH differentiation. Evidence also supports the proposal of their involvement in the responses of T reg cells, CD8 + T cells and perhaps T H 2 cells. They seem to have little involvement in T H 1 immunity. LCs share many of those functions with other DC subsets and are non-redundant mainly in contexts in which antigen is confined or concentrated to the epidermis. This fits well with the concept that an individual DC subset has the potential to promote several but not all helper T cell phenotypes and that the ultimate T cell response is dictated by a combination of the location of the antigen, the DC subset presenting the antigen and the microbe-associated molecular pattern and/or cytokine environment. Despite progress, there are several aspects of LC biology that remain poorly defined. The relationship of LCs with immunological effector cells within the epidermis, the interaction of LCs with cells of the innate immune system, including KCs, the effect of the presentation of lipid molecules by LCs via CD1a, and whether LCs share a functional as well as an ontogenetic relationship with macrophages all remain to be fully explored. These represent major frontiers for future exploration.
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